Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 488 abstracts

no pagination
Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen CH. INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCER. International Journal of Radiation Oncology Biology Physics. 2010 Nov;78(4):1020-5.   PMCID: not NIH funded
Showalter SL, Rosato EL, Anne PR, Scott W, Mitchell E, Berger AC. Does Diabetes Mellitus Influence Pathologic Complete Response and Tumor Downstaging After Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Cancer? A Two-Institution Report. Journal of surgical oncology. 2010 Jan;101(1):43-6.   PMCID: not NIH funded
van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin XA, Herring J, Casper C, Kurzrock R. Siltuximab, a Novel Anti-Interleukin-6 Monoclonal Antibody, for Castleman's Disease. Journal of Clinical Oncology. 2010 Aug;28(23):3701-8.   PMCID: Not required
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors. American Journal of Pathology. 2009 Dec;175(6):2657-67.   PMCID: PMC2789618
Boorjian SA, Berglund RK, Maschino AC, Savage CJ, Herr HW. Fibrin Clot Inhibitor Medication and Efficacy of Bacillus Calmette-Guerin for Bladder Urothelial Cancer. Journal of Urology. 2009 Oct;182(4):1306-11.
Boorjian SA, Blute ML. Surgery for vena caval tumor extension in renal cancer. Current opinion in urology. 2009 Sep;19(5):473-7.
Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. European journal of pharmacology. 2009 Dec 25;625(1-3):41-54.   PMCID: PMC2783916
Coups EJ, Dhingra LK, Heckman CJ, Manne SL. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009 Nov;24 Suppl 2:S480-6.   PMCID: PMC2763168
Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB, Shibata S, Romanus D, Niland J, Schrag D. Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer. Journal of surgical oncology. 2009 Dec;100(7):525-8.   PMCID: not NIH funded
Egleston BL, Wong YN. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Statistics in medicine. 2009 May;28(10):1498-511.   PMCID: PMC2741403
Enders GH. Wnt therapy for bone loss: golden goose or Trojan horse?. J Clin Invest. 2009 Apr;119(4):758-60.   PMCID: PMC2662580
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):838-81.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer N. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep;7(8):778-831.   PMCID: not NIH funded
Figlin RA, de Souza P, McDermott D, Dutcher JP, Berkenblit A, Thiele A, Krygowski M, Strahs A, Feingold J, Boni J, Hudes G. Analysis of PTEN and HIF-1 alpha and Correlation With Efficacy in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus Versus Interferon-alpha. Cancer. 2009 Aug;115(16):3651-60.   PMCID: not NIH funded
Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A. MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. J Clin Oncol. 2009 Jul;27(19):3177-84.   PMCID: PMC2716939
Martinez E, Tatum KL, Weber DM, Kuzla N, Pendley A, Campbell K, Ridge JA, Langer C, Miyamoto C, Schnoll RA. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer causes & control : CCC. 2009 Feb;20(1):97-104.   PMCID: PMC2628415
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE, American Society of Clinical O. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10;27(23):3868-74.
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009 Jun;7 Suppl 2:S1-26.
Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 2009 Aug;8(8):2172-82.   PMCID: PMC2822341
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy Neoplasms Male Female methods carcinoma Aged diagnosis mortality Middle Aged 80 and over Aged Treatment Outcome tyrosine kinase inhibitor growth phase-iii trial Adult genetics chemotherapy fluorouracil Smoking Cessation surgery Physician-Patient Relations epidemiology Patient Education as Topic Prognosis Neoplasm Staging survival therapeutic use radiotherapy pathology zinc-finger genes mtor inhibitor Biomedical Technology in-vivo targeted Computer-Assisted Image Interpretation kidney cancer renal cell carcinoma squamous-cell carcinoma donor lymphocyte infusions Osteoporosis receptor thrombus extension genes progression analysis antitumor-activity Combined Modality Therapy Gene Expression complications Tumor Suppressor Protein p53 gastroesophageal cancer Hormonal Antineoplastic Agents interleukin-6 vein Sensitivity and Specificity chemoradiotherapy breast-cancer Monoclonal Antibodies risk adverse effects radical nephrectomy Intercellular Signaling Peptides and Proteins Proto-Oncogene Proteins c-mdm2 folinic acid stem-cell transplantation agonists Antineoplastic Agents cancer Kaplan-Meier Estimate plus cetuximab Cost-Benefit Analysis immunotherapy colorectal-cancer leukemia colon cancer progenitor cells rectal-cancer Health Surveys numerical data curative resection gists statistics & metabolism Dendritic Cells classification Signal Transducing Adaptor Proteins gastric cardia stroma Ki-67 Antigen adenocarcinoma Osteosarcoma circulatory arrest Toll-Like Receptors Radioimmunotherapy pathway Survival Analysis thrombectomy Drug Industry allogenic HSCT Communication polymerase-chain-reaction urinary-bladder LN retrieval diagnostic use Health Personnel response Reirradiation venous tumor thrombus diabetes mellitus transplantation SEER Program hematopoietic stem Immunohistochemistry Positron-Emission Tomography Medical Education-Continuing kit mutations prognostic-significance Proportional Hazards Models complete cytogenetic mammalian target kinase inhibitor Tumor Biomarkers metaanalysis deficiency Young Adult Registries Prostatic Neoplasms Survivors resistance differential-diagnosis transitional-cell carcinoma Biological Models angiogenesis etiology Gene Silencing Insurance Coverage Analysis of Variance Rectal Neoplasms Algorithms chronic myeloid-leukemia Colonic Neoplasms Statistical Data Interpretation cooperative-oncology-group Radiotherapy Double-Blind Method Kidney Neoplasms Biometry prognostic-factors Adolescent
Last updated on Tuesday, August 04, 2020